Arrowpoint Investment Partners (Singapore) Pte. Ltd. VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in Arrowpoint Investment Partners (Singapore) Pte. Ltd.  ·  8 quarters on record

AI Ownership Summary

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported VERTEX PHARMACEUTICALS INC (VRTX) in 8 quarterly 13F filings from 2024 Q4 through 2026 Q3. Peak portfolio weight reached 1.35% in 2026 Q1. The latest visible filing shows VRTX at 1.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s position in VERTEX PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

VRTX was reported at 1.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.35% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Arrowpoint Investment Partners (Singapore) Pte. Ltd. held VRTX — position size vs. price
% of Fund (quarterly)    VRTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 ADDED — — — 44,805 +41,393 +1213.2% 1.02% $23.4M 2026-11-12 $542.62
2026 Q1 ADDED — — — 3,412 +48 +1.4% 1.35% $1.5M 2026-05-14 $450.41
2025 Q4 ADDED — — — 3,364 +2,907 +636.1% 0.22% $1.5M 2026-02-11 $461.24
2025 Q1 REDUCED 77.1% -8.2% ✅ 457 -1,543 -77.1% 0.03% $222K 2025-05-13 $432.00
2025 Q1 ADDED — — — 2,000 +400 +25.0% 0.11% $970K 2025-05-13 $432.00
2025 Q1 REDUCED 59.0% -8.2% ✅ 1,600 -2,300 -59.0% 0.09% $776K 2025-05-13 $432.00
2024 Q4 REDUCED 15.2% +20.4% ❌ 3,900 -700 -15.2% 0.32% $1.6M 2025-02-18 $462.11
2024 Q4 INITIATED — — — 4,600 — — 0.38% $1.9M 2025-02-18 $462.11

FAQ About Arrowpoint Investment Partners (Singapore) Pte. Ltd. and VRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported owning VRTX?

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported VRTX across 8 quarterly 13F filings, from 2024 Q4 through 2026 Q3.

What was the largest reported VRTX position in Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s portfolio?

The largest reported portfolio weight for VRTX was 1.35% in 2026 Q1.

What is the latest reported VRTX position on this page?

The most recent filing on this page is 2026 Q3, when Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported 44,805 shares, equal to 1.02% of portfolio, with an estimated market value of $23.4M.

What does the chart on this VRTX ownership page compare?

The chart compares Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s quarterly VRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Arrowpoint Investment Partners (Singapore) Pte. Ltd. time their VRTX position?

Based on 13F filing dates vs. subsequent VRTX price moves, Arrowpoint Investment Partners (Singapore) Pte. Ltd. correctly timed 3 out of 7 reported position changes (43%). The annualised alpha on VRTX relative to SPY over the holding period was +3.7%.

← Back to Arrowpoint Investment Partners (Singapore) Pte. Ltd. Holdings